Skip to main content
Clinical Trials/JPRN-UMIN000010071
JPRN-UMIN000010071
Completed
未知

Drug Eluting stent implantation vs BAre metal sTEnt implantation in treatment of SFA - DEBATE in SFA

Shinshu university hospital0 sites360 target enrollmentFebruary 18, 2013

Overview

Phase
未知
Intervention
Not specified
Conditions
Patient with Peripheral Artery Disease
Sponsor
Shinshu university hospital
Enrollment
360
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 18, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Exclusion criteria Patient criteria Patients who meet any of the following criteria should be excluded from the study: 1\.Patients with or at risk of hemorrhagic complications or patients with bleeding\* tendency \*Bleeding such as hemophilia, capillary fragility, intracranial hemorrhage, gastrointestinal hemorrhage, urinary tract hemorrhage, hemoptysis, or vitreous hemorrhage may be aggravated. 2\.Patients with congestive cardiac failure (NYHA III or IV or EF\<30%) 3\.Patients implanted a drug\-eluting stent (DES) within 3months 4\.patients with a history of serious adverse reaction such as leukopenia, hepatic dysfunction, or renal dysfunction, or hypersensitivity to any component of the study drug. 5\.Pregnant or potentially pregnant women 6\.Patients with acute lower limb ischemia 7\.Patients who are not eligible for the study in the opinion of the attending physician. Lesion criteria Lesions that meet any of the following criteria should be excluded from the study: 1\.Remnant inflow (aorta\-iliac artery lesion) 2\.Severe calcification (lesions not expected to be appropriately expanded)

Outcomes

Primary Outcomes

Not specified

Similar Trials